Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare data
- PMID: 40726731
- PMCID: PMC12302703
- DOI: 10.1016/j.ssmmh.2024.100323
Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare data
Abstract
Background: Ovarian cancer (OC) patients have an increased risk for a mental health illness (MHI) after their cancer diagnosis, but limited research exists on whether this risk differs by race/ethnicity. Hence, we used SEER-Medicare data to evaluate racial/ethnic differences in MHI incidence among OC patients aged 65+.
Methods: Non-Hispanic (NH) Black, NH White, and Hispanic women diagnosed with OC in 2008-2015 without a mental health history 12 months prior to their cancer diagnosis were identified from SEER-Medicare. Cox proportional hazards regression evaluated new MHI incidence in the first five years post diagnosis and the differences by race/ethnicity. Hazard ratios (HR) and 95% confidence intervals (CI) adjusted for demographic/clinical covariates and healthcare access (HCA) dimensions.
Results: We identified 5441 OC patients, including 364 NH Black (6.7%), 4982 NH White (91.6%), and 95 Hispanic (1.7%) patients. About 41% of NH White, 33.3% of NH Black, and 37.2% of Hispanic OC patients were diagnosed with MHI during the follow-up period between 2008 and 2016. In the fully adjusted model, NH Black OC patients were less likely to be diagnosed with any MHI (aHR: 0.67, 95% CI: 0.54, 0.82), depression (aHR: 0.66, 95% CI: 0.51, 0.86), and anxiety disorder (aHR: 0.64, 95% CI: 0.49, 0.84), while Hispanic OC patients were less likely to be diagnosed with anxiety disorder (aHR: 0.56, 95% CI: 0.33, 0.95) compared to NH White OC patients.
Discussion: NH Black OC patients are less likely to receive a clinical MHI diagnosis compared to NH White OC patients. Further studies on racial differences in MHI incidence after OC diagnosis in primary cohorts are needed to better estimate population-level prevalence less vulnerable to exposure misclassification and to account for patient-level factors impacting MHI.
Keywords: Healthcare access; Mental health; Mental health diagnosis; Ovarian cancer; Racial disparities.
Figures


Similar articles
-
Racial and ethnic disparities in fecundability: a North American preconception cohort study.Hum Reprod. 2025 Jun 1;40(6):1183-1194. doi: 10.1093/humrep/deaf067. Hum Reprod. 2025. PMID: 40246287
-
Health care access domains and treatment as mediators of ovarian cancer racial disparities in survival: a structural equation modeling analysis in SEER-Medicare.Am J Epidemiol. 2025 Aug 5;194(8):2230-2240. doi: 10.1093/aje/kwae404. Am J Epidemiol. 2025. PMID: 39479786
-
Understanding patient pathways to Mother and Baby Units: a longitudinal retrospective service evaluation in the UK.Health Soc Care Deliv Res. 2025 Jul 16:1-17. doi: 10.3310/GDVS2427. Online ahead of print. Health Soc Care Deliv Res. 2025. PMID: 40682791
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
References
Grants and funding
LinkOut - more resources
Full Text Sources